nodes	percent_of_prediction	percent_of_DWPC	metapath
Carglumic Acid—CPS1—prostate gland—urinary bladder cancer	0.128	0.424	CbGeAlD
Carglumic Acid—CPS1—female reproductive system—urinary bladder cancer	0.0701	0.231	CbGeAlD
Carglumic Acid—CPS1—vagina—urinary bladder cancer	0.0634	0.209	CbGeAlD
Carglumic Acid—CPS1—Podofilox—Etoposide—urinary bladder cancer	0.0497	1	CbGdCrCtD
Carglumic Acid—CPS1—lymph node—urinary bladder cancer	0.041	0.135	CbGeAlD
Carglumic Acid—Glutathione—GSTZ1—urinary bladder cancer	0.023	0.322	CrCbGaD
Carglumic Acid—Glutathione—GSTO2—urinary bladder cancer	0.023	0.322	CrCbGaD
Carglumic Acid—Transaminases increased—Thiotepa—urinary bladder cancer	0.0147	0.0256	CcSEcCtD
Carglumic Acid—Pneumonia—Valrubicin—urinary bladder cancer	0.0146	0.0253	CcSEcCtD
Carglumic Acid—Transaminases increased—Gemcitabine—urinary bladder cancer	0.0124	0.0215	CcSEcCtD
Carglumic Acid—Anaemia—Valrubicin—urinary bladder cancer	0.0105	0.0182	CcSEcCtD
Carglumic Acid—Infection—Carboplatin—urinary bladder cancer	0.0085	0.0147	CcSEcCtD
Carglumic Acid—Glutathione—GPX1—urinary bladder cancer	0.00823	0.116	CrCbGaD
Carglumic Acid—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00755	0.0131	CcSEcCtD
Carglumic Acid—Body temperature increased—Valrubicin—urinary bladder cancer	0.0073	0.0127	CcSEcCtD
Carglumic Acid—Abdominal pain—Valrubicin—urinary bladder cancer	0.0073	0.0127	CcSEcCtD
Carglumic Acid—Anaemia—Mitomycin—urinary bladder cancer	0.00721	0.0125	CcSEcCtD
Carglumic Acid—Glutathione—HPGDS—urinary bladder cancer	0.0068	0.0954	CrCbGaD
Carglumic Acid—Body temperature increased—Carboplatin—urinary bladder cancer	0.00676	0.0117	CcSEcCtD
Carglumic Acid—Asthenia—Valrubicin—urinary bladder cancer	0.00663	0.0115	CcSEcCtD
Carglumic Acid—Diarrhoea—Valrubicin—urinary bladder cancer	0.00632	0.011	CcSEcCtD
Carglumic Acid—Anorexia—Mitomycin—urinary bladder cancer	0.00607	0.0105	CcSEcCtD
Carglumic Acid—Transaminases increased—Epirubicin—urinary bladder cancer	0.00594	0.0103	CcSEcCtD
Carglumic Acid—Vomiting—Valrubicin—urinary bladder cancer	0.00587	0.0102	CcSEcCtD
Carglumic Acid—Rash—Valrubicin—urinary bladder cancer	0.00582	0.0101	CcSEcCtD
Carglumic Acid—Dermatitis—Valrubicin—urinary bladder cancer	0.00582	0.0101	CcSEcCtD
Carglumic Acid—Headache—Valrubicin—urinary bladder cancer	0.00579	0.01	CcSEcCtD
Carglumic Acid—Somnolence—Mitomycin—urinary bladder cancer	0.00566	0.00982	CcSEcCtD
Carglumic Acid—Decreased appetite—Mitomycin—urinary bladder cancer	0.00553	0.0096	CcSEcCtD
Carglumic Acid—Transaminases increased—Doxorubicin—urinary bladder cancer	0.00549	0.00953	CcSEcCtD
Carglumic Acid—Pneumonia—Thiotepa—urinary bladder cancer	0.00505	0.00876	CcSEcCtD
Carglumic Acid—Body temperature increased—Mitomycin—urinary bladder cancer	0.00503	0.00873	CcSEcCtD
Carglumic Acid—Infestation NOS—Thiotepa—urinary bladder cancer	0.00502	0.00871	CcSEcCtD
Carglumic Acid—Infestation—Thiotepa—urinary bladder cancer	0.00502	0.00871	CcSEcCtD
Carglumic Acid—Nasopharyngitis—Fluorouracil—urinary bladder cancer	0.00482	0.00836	CcSEcCtD
Carglumic Acid—Influenza—Gemcitabine—urinary bladder cancer	0.00473	0.00821	CcSEcCtD
Carglumic Acid—Asthenia—Mitomycin—urinary bladder cancer	0.00457	0.00792	CcSEcCtD
Carglumic Acid—Nasopharyngitis—Cisplatin—urinary bladder cancer	0.00456	0.00792	CcSEcCtD
Carglumic Acid—Diarrhoea—Mitomycin—urinary bladder cancer	0.00435	0.00755	CcSEcCtD
Carglumic Acid—Sweating increased—Cisplatin—urinary bladder cancer	0.0043	0.00746	CcSEcCtD
Carglumic Acid—Pneumonia—Gemcitabine—urinary bladder cancer	0.00425	0.00737	CcSEcCtD
Carglumic Acid—Cardiac disorder—Thiotepa—urinary bladder cancer	0.00418	0.00725	CcSEcCtD
Carglumic Acid—Pneumonia—Fluorouracil—urinary bladder cancer	0.00417	0.00724	CcSEcCtD
Carglumic Acid—Infestation—Fluorouracil—urinary bladder cancer	0.00415	0.0072	CcSEcCtD
Carglumic Acid—Infestation NOS—Fluorouracil—urinary bladder cancer	0.00415	0.0072	CcSEcCtD
Carglumic Acid—Vomiting—Mitomycin—urinary bladder cancer	0.00405	0.00702	CcSEcCtD
Carglumic Acid—Rash—Mitomycin—urinary bladder cancer	0.00401	0.00696	CcSEcCtD
Carglumic Acid—Dermatitis—Mitomycin—urinary bladder cancer	0.00401	0.00696	CcSEcCtD
Carglumic Acid—Headache—Mitomycin—urinary bladder cancer	0.00399	0.00692	CcSEcCtD
Carglumic Acid—Sweating increased—Etoposide—urinary bladder cancer	0.00394	0.00683	CcSEcCtD
Carglumic Acid—Malnutrition—Thiotepa—urinary bladder cancer	0.00392	0.0068	CcSEcCtD
Carglumic Acid—Glutathione—GSTT1—urinary bladder cancer	0.00389	0.0545	CrCbGaD
Carglumic Acid—Pneumonia—Etoposide—urinary bladder cancer	0.00362	0.00629	CcSEcCtD
Carglumic Acid—Anaemia—Thiotepa—urinary bladder cancer	0.00362	0.00629	CcSEcCtD
Carglumic Acid—Infestation NOS—Etoposide—urinary bladder cancer	0.0036	0.00625	CcSEcCtD
Carglumic Acid—Infestation—Etoposide—urinary bladder cancer	0.0036	0.00625	CcSEcCtD
Carglumic Acid—Bradycardia—Cisplatin—urinary bladder cancer	0.0036	0.00624	CcSEcCtD
Carglumic Acid—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.00352	0.0061	CcSEcCtD
Carglumic Acid—Glutathione—GSTM1—urinary bladder cancer	0.00332	0.0466	CrCbGaD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.00332	0.00575	CcSEcCtD
Carglumic Acid—Cardiac disorder—Cisplatin—urinary bladder cancer	0.00328	0.00569	CcSEcCtD
Carglumic Acid—Infection—Thiotepa—urinary bladder cancer	0.00318	0.00552	CcSEcCtD
Carglumic Acid—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00314	0.00545	CcSEcCtD
Carglumic Acid—Skin disorder—Thiotepa—urinary bladder cancer	0.00311	0.00539	CcSEcCtD
Carglumic Acid—Malnutrition—Cisplatin—urinary bladder cancer	0.00307	0.00533	CcSEcCtD
Carglumic Acid—Glutathione—GSTP1—urinary bladder cancer	0.00307	0.0431	CrCbGaD
Carglumic Acid—Anorexia—Thiotepa—urinary bladder cancer	0.00305	0.00529	CcSEcCtD
Carglumic Acid—Anaemia—Gemcitabine—urinary bladder cancer	0.00305	0.00529	CcSEcCtD
Carglumic Acid—Cardiac disorder—Etoposide—urinary bladder cancer	0.003	0.00521	CcSEcCtD
Carglumic Acid—Anaemia—Fluorouracil—urinary bladder cancer	0.003	0.0052	CcSEcCtD
Carglumic Acid—Somnolence—Thiotepa—urinary bladder cancer	0.00284	0.00494	CcSEcCtD
Carglumic Acid—Anaemia—Cisplatin—urinary bladder cancer	0.00284	0.00493	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00279	0.00484	CcSEcCtD
Carglumic Acid—Decreased appetite—Thiotepa—urinary bladder cancer	0.00278	0.00483	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00276	0.00479	CcSEcCtD
Carglumic Acid—Dysgeusia—Etoposide—urinary bladder cancer	0.00276	0.00479	CcSEcCtD
Carglumic Acid—Infection—Gemcitabine—urinary bladder cancer	0.00267	0.00464	CcSEcCtD
Carglumic Acid—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00264	0.00458	CcSEcCtD
Carglumic Acid—Infection—Fluorouracil—urinary bladder cancer	0.00263	0.00456	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00262	0.00454	CcSEcCtD
Carglumic Acid—Skin disorder—Gemcitabine—urinary bladder cancer	0.00261	0.00454	CcSEcCtD
Carglumic Acid—Anaemia—Etoposide—urinary bladder cancer	0.0026	0.00452	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.0026	0.00452	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.0026	0.00451	CcSEcCtD
Carglumic Acid—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.0026	0.0045	CcSEcCtD
Carglumic Acid—Anorexia—Gemcitabine—urinary bladder cancer	0.00257	0.00445	CcSEcCtD
Carglumic Acid—Abdominal pain—Thiotepa—urinary bladder cancer	0.00253	0.00439	CcSEcCtD
Carglumic Acid—Body temperature increased—Thiotepa—urinary bladder cancer	0.00253	0.00439	CcSEcCtD
Carglumic Acid—Anorexia—Fluorouracil—urinary bladder cancer	0.00252	0.00438	CcSEcCtD
Carglumic Acid—Infection—Cisplatin—urinary bladder cancer	0.00249	0.00433	CcSEcCtD
Carglumic Acid—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00246	0.00427	CcSEcCtD
Carglumic Acid—Skin disorder—Cisplatin—urinary bladder cancer	0.00244	0.00423	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00243	0.00421	CcSEcCtD
Carglumic Acid—Somnolence—Gemcitabine—urinary bladder cancer	0.00239	0.00415	CcSEcCtD
Carglumic Acid—Anorexia—Cisplatin—urinary bladder cancer	0.00239	0.00415	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00238	0.00413	CcSEcCtD
Carglumic Acid—Somnolence—Fluorouracil—urinary bladder cancer	0.00235	0.00408	CcSEcCtD
Carglumic Acid—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.00234	0.00407	CcSEcCtD
Carglumic Acid—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00234	0.00406	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00232	0.00403	CcSEcCtD
Carglumic Acid—Decreased appetite—Fluorouracil—urinary bladder cancer	0.0023	0.00399	CcSEcCtD
Carglumic Acid—Asthenia—Thiotepa—urinary bladder cancer	0.0023	0.00398	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00228	0.00396	CcSEcCtD
Carglumic Acid—Infection—Etoposide—urinary bladder cancer	0.00228	0.00396	CcSEcCtD
Carglumic Acid—Influenza—Epirubicin—urinary bladder cancer	0.00227	0.00393	CcSEcCtD
Carglumic Acid—Skin disorder—Etoposide—urinary bladder cancer	0.00223	0.00387	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00222	0.00386	CcSEcCtD
Carglumic Acid—Anorexia—Etoposide—urinary bladder cancer	0.00219	0.0038	CcSEcCtD
Carglumic Acid—Diarrhoea—Thiotepa—urinary bladder cancer	0.00219	0.0038	CcSEcCtD
Carglumic Acid—Decreased appetite—Cisplatin—urinary bladder cancer	0.00218	0.00378	CcSEcCtD
Carglumic Acid—Pneumonia—Methotrexate—urinary bladder cancer	0.00217	0.00377	CcSEcCtD
Carglumic Acid—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.00217	0.00376	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00217	0.00376	CcSEcCtD
Carglumic Acid—Infestation NOS—Methotrexate—urinary bladder cancer	0.00216	0.00375	CcSEcCtD
Carglumic Acid—Infestation—Methotrexate—urinary bladder cancer	0.00216	0.00375	CcSEcCtD
Carglumic Acid—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00213	0.00369	CcSEcCtD
Carglumic Acid—Influenza—Doxorubicin—urinary bladder cancer	0.0021	0.00364	CcSEcCtD
Carglumic Acid—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00209	0.00363	CcSEcCtD
Carglumic Acid—Weight decreased—Epirubicin—urinary bladder cancer	0.00205	0.00356	CcSEcCtD
Carglumic Acid—Somnolence—Etoposide—urinary bladder cancer	0.00204	0.00355	CcSEcCtD
Carglumic Acid—Vomiting—Thiotepa—urinary bladder cancer	0.00203	0.00353	CcSEcCtD
Carglumic Acid—Pneumonia—Epirubicin—urinary bladder cancer	0.00203	0.00353	CcSEcCtD
Carglumic Acid—Infestation NOS—Epirubicin—urinary bladder cancer	0.00202	0.00351	CcSEcCtD
Carglumic Acid—Infestation—Epirubicin—urinary bladder cancer	0.00202	0.00351	CcSEcCtD
Carglumic Acid—Rash—Thiotepa—urinary bladder cancer	0.00202	0.0035	CcSEcCtD
Carglumic Acid—Dermatitis—Thiotepa—urinary bladder cancer	0.00202	0.0035	CcSEcCtD
Carglumic Acid—Headache—Thiotepa—urinary bladder cancer	0.002	0.00348	CcSEcCtD
Carglumic Acid—Decreased appetite—Etoposide—urinary bladder cancer	0.002	0.00347	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00198	0.00344	CcSEcCtD
Carglumic Acid—Body temperature increased—Cisplatin—urinary bladder cancer	0.00198	0.00344	CcSEcCtD
Carglumic Acid—Asthenia—Gemcitabine—urinary bladder cancer	0.00193	0.00335	CcSEcCtD
Carglumic Acid—Weight decreased—Doxorubicin—urinary bladder cancer	0.0019	0.00329	CcSEcCtD
Carglumic Acid—Pneumonia—Doxorubicin—urinary bladder cancer	0.00188	0.00326	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00188	0.00326	CcSEcCtD
Carglumic Acid—Infestation NOS—Doxorubicin—urinary bladder cancer	0.00187	0.00324	CcSEcCtD
Carglumic Acid—Infestation—Doxorubicin—urinary bladder cancer	0.00187	0.00324	CcSEcCtD
Carglumic Acid—Bradycardia—Epirubicin—urinary bladder cancer	0.00185	0.0032	CcSEcCtD
Carglumic Acid—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00184	0.0032	CcSEcCtD
Carglumic Acid—Abdominal pain—Etoposide—urinary bladder cancer	0.00182	0.00315	CcSEcCtD
Carglumic Acid—Body temperature increased—Etoposide—urinary bladder cancer	0.00182	0.00315	CcSEcCtD
Carglumic Acid—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00181	0.00314	CcSEcCtD
Carglumic Acid—Asthenia—Cisplatin—urinary bladder cancer	0.0018	0.00312	CcSEcCtD
Carglumic Acid—Cardiac disorder—Methotrexate—urinary bladder cancer	0.0018	0.00312	CcSEcCtD
Carglumic Acid—Diarrhoea—Cisplatin—urinary bladder cancer	0.00172	0.00298	CcSEcCtD
Carglumic Acid—Vomiting—Gemcitabine—urinary bladder cancer	0.00171	0.00297	CcSEcCtD
Carglumic Acid—Bradycardia—Doxorubicin—urinary bladder cancer	0.00171	0.00296	CcSEcCtD
Carglumic Acid—Rash—Gemcitabine—urinary bladder cancer	0.0017	0.00295	CcSEcCtD
Carglumic Acid—Dermatitis—Gemcitabine—urinary bladder cancer	0.0017	0.00294	CcSEcCtD
Carglumic Acid—Malnutrition—Methotrexate—urinary bladder cancer	0.00169	0.00293	CcSEcCtD
Carglumic Acid—Headache—Gemcitabine—urinary bladder cancer	0.00169	0.00293	CcSEcCtD
Carglumic Acid—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00168	0.00292	CcSEcCtD
Carglumic Acid—Vomiting—Fluorouracil—urinary bladder cancer	0.00168	0.00292	CcSEcCtD
Carglumic Acid—Rash—Fluorouracil—urinary bladder cancer	0.00167	0.0029	CcSEcCtD
Carglumic Acid—Dermatitis—Fluorouracil—urinary bladder cancer	0.00167	0.00289	CcSEcCtD
Carglumic Acid—Headache—Fluorouracil—urinary bladder cancer	0.00166	0.00288	CcSEcCtD
Carglumic Acid—Dysgeusia—Methotrexate—urinary bladder cancer	0.00165	0.00287	CcSEcCtD
Carglumic Acid—Asthenia—Etoposide—urinary bladder cancer	0.00165	0.00286	CcSEcCtD
Carglumic Acid—Vomiting—Cisplatin—urinary bladder cancer	0.0016	0.00277	CcSEcCtD
Carglumic Acid—Rash—Cisplatin—urinary bladder cancer	0.00158	0.00275	CcSEcCtD
Carglumic Acid—Dermatitis—Cisplatin—urinary bladder cancer	0.00158	0.00274	CcSEcCtD
Carglumic Acid—Malnutrition—Epirubicin—urinary bladder cancer	0.00158	0.00274	CcSEcCtD
Carglumic Acid—Diarrhoea—Etoposide—urinary bladder cancer	0.00157	0.00273	CcSEcCtD
Carglumic Acid—Anaemia—Methotrexate—urinary bladder cancer	0.00156	0.00271	CcSEcCtD
Carglumic Acid—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.00156	0.0027	CcSEcCtD
Carglumic Acid—Dysgeusia—Epirubicin—urinary bladder cancer	0.00155	0.00268	CcSEcCtD
Carglumic Acid—Vomiting—Etoposide—urinary bladder cancer	0.00146	0.00254	CcSEcCtD
Carglumic Acid—Malnutrition—Doxorubicin—urinary bladder cancer	0.00146	0.00253	CcSEcCtD
Carglumic Acid—Anaemia—Epirubicin—urinary bladder cancer	0.00146	0.00253	CcSEcCtD
Carglumic Acid—Rash—Etoposide—urinary bladder cancer	0.00145	0.00251	CcSEcCtD
Carglumic Acid—Dermatitis—Etoposide—urinary bladder cancer	0.00145	0.00251	CcSEcCtD
Carglumic Acid—Headache—Etoposide—urinary bladder cancer	0.00144	0.0025	CcSEcCtD
Carglumic Acid—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00143	0.00248	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00143	0.00247	CcSEcCtD
Carglumic Acid—Infection—Methotrexate—urinary bladder cancer	0.00137	0.00237	CcSEcCtD
Carglumic Acid—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00135	0.00234	CcSEcCtD
Carglumic Acid—Anaemia—Doxorubicin—urinary bladder cancer	0.00135	0.00234	CcSEcCtD
Carglumic Acid—Skin disorder—Methotrexate—urinary bladder cancer	0.00134	0.00232	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00133	0.00232	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00133	0.00231	CcSEcCtD
Carglumic Acid—Anorexia—Methotrexate—urinary bladder cancer	0.00131	0.00228	CcSEcCtD
Carglumic Acid—Infection—Epirubicin—urinary bladder cancer	0.00128	0.00222	CcSEcCtD
Carglumic Acid—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00126	0.00219	CcSEcCtD
Carglumic Acid—Skin disorder—Epirubicin—urinary bladder cancer	0.00125	0.00217	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00125	0.00216	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00124	0.00214	CcSEcCtD
Carglumic Acid—Anorexia—Epirubicin—urinary bladder cancer	0.00123	0.00213	CcSEcCtD
Carglumic Acid—Somnolence—Methotrexate—urinary bladder cancer	0.00122	0.00212	CcSEcCtD
Carglumic Acid—Decreased appetite—Methotrexate—urinary bladder cancer	0.0012	0.00208	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00119	0.00206	CcSEcCtD
Carglumic Acid—Infection—Doxorubicin—urinary bladder cancer	0.00118	0.00206	CcSEcCtD
Carglumic Acid—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00117	0.00203	CcSEcCtD
Carglumic Acid—Skin disorder—Doxorubicin—urinary bladder cancer	0.00116	0.00201	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00115	0.002	CcSEcCtD
Carglumic Acid—Somnolence—Epirubicin—urinary bladder cancer	0.00115	0.00199	CcSEcCtD
Carglumic Acid—Anorexia—Doxorubicin—urinary bladder cancer	0.00114	0.00197	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00113	0.00195	CcSEcCtD
Carglumic Acid—Decreased appetite—Epirubicin—urinary bladder cancer	0.00112	0.00194	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00111	0.00193	CcSEcCtD
Carglumic Acid—Abdominal pain—Methotrexate—urinary bladder cancer	0.00109	0.00189	CcSEcCtD
Carglumic Acid—Body temperature increased—Methotrexate—urinary bladder cancer	0.00109	0.00189	CcSEcCtD
Carglumic Acid—Somnolence—Doxorubicin—urinary bladder cancer	0.00106	0.00184	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00105	0.00183	CcSEcCtD
Carglumic Acid—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00104	0.0018	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00103	0.00179	CcSEcCtD
Carglumic Acid—Body temperature increased—Epirubicin—urinary bladder cancer	0.00102	0.00177	CcSEcCtD
Carglumic Acid—Abdominal pain—Epirubicin—urinary bladder cancer	0.00102	0.00177	CcSEcCtD
Carglumic Acid—Asthenia—Methotrexate—urinary bladder cancer	0.000988	0.00171	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000975	0.00169	CcSEcCtD
Carglumic Acid—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000942	0.00164	CcSEcCtD
Carglumic Acid—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000942	0.00164	CcSEcCtD
Carglumic Acid—Diarrhoea—Methotrexate—urinary bladder cancer	0.000942	0.00163	CcSEcCtD
Carglumic Acid—Asthenia—Epirubicin—urinary bladder cancer	0.000924	0.0016	CcSEcCtD
Carglumic Acid—Diarrhoea—Epirubicin—urinary bladder cancer	0.000882	0.00153	CcSEcCtD
Carglumic Acid—Vomiting—Methotrexate—urinary bladder cancer	0.000875	0.00152	CcSEcCtD
Carglumic Acid—Rash—Methotrexate—urinary bladder cancer	0.000868	0.00151	CcSEcCtD
Carglumic Acid—Dermatitis—Methotrexate—urinary bladder cancer	0.000867	0.0015	CcSEcCtD
Carglumic Acid—Headache—Methotrexate—urinary bladder cancer	0.000863	0.0015	CcSEcCtD
Carglumic Acid—Asthenia—Doxorubicin—urinary bladder cancer	0.000855	0.00148	CcSEcCtD
Carglumic Acid—Vomiting—Epirubicin—urinary bladder cancer	0.000819	0.00142	CcSEcCtD
Carglumic Acid—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000816	0.00142	CcSEcCtD
Carglumic Acid—Rash—Epirubicin—urinary bladder cancer	0.000812	0.00141	CcSEcCtD
Carglumic Acid—Dermatitis—Epirubicin—urinary bladder cancer	0.000812	0.00141	CcSEcCtD
Carglumic Acid—Headache—Epirubicin—urinary bladder cancer	0.000807	0.0014	CcSEcCtD
Carglumic Acid—Vomiting—Doxorubicin—urinary bladder cancer	0.000758	0.00132	CcSEcCtD
Carglumic Acid—Rash—Doxorubicin—urinary bladder cancer	0.000752	0.0013	CcSEcCtD
Carglumic Acid—Dermatitis—Doxorubicin—urinary bladder cancer	0.000751	0.0013	CcSEcCtD
Carglumic Acid—Headache—Doxorubicin—urinary bladder cancer	0.000747	0.0013	CcSEcCtD
